Summary
Acute poisoning with organic solvents and other volatile compounds now usually follows deliberate inhalation (volatile substance abuse) or ingestion of these compounds. Solvents from adhesives, typewriter correction and dry cleaning fluids, cigarette lighter refills (butane) and aerosol propellants are commonly abused. The major risk is that of sudden death. Arrhythmias leading to cardiac arrest are thought to cause most deaths, but anoxia, respiratory depression and vagal stimulation leading to cardiac arrest may also contribute, as may indirect causes such as aspiration of vomit or trauma.
In the United Kingdom (UK), 3.5 to 10% of young people have at least experimented with volatile substance abuse and mortality is more than 100 per annum. The products abused are cheap and readily available despite legislation designed to limit supply. Volatile substance abuse is not illegal and only a minority of abusers are known to progress to heavy alcohol or illicit drug use. Prevention of abuse by education, not only of children but also of parents, teachers, retailers and health care workers, is important in limiting the problem. However, volatile substance abuse-related deaths are still increasing in the UK despite many measures aimed at prevention.
Clinically, volatile substance abuse is characterised by a rapid onset of intoxication and rapid recovery. Euphoria and disinhibition may be followed by hallucinations, tinnitus, ataxia, confusion, nausea and vomiting. It is important not to further alarm the patient if signs of serious toxicity are present, since a cardiac arrest may be precipitated. Further exposure should be prevented and the patient resuscitated and given supplemental oxygen if necessary. Cardiac arrhythmias should be treated conventionally and respiratory failure managed supportively. Long term exposure to n-hexane is associated with the development of peripheral neuropathy, while prolonged abuse (notably of toluene or chlorinated solvents) can cause permanent damage to the central nervous system, heart, liver, kidney and lungs.
Knowledge of the routes of absorption, distribution and excretion of volatile compounds, and of the rates governing these processes, is important in understanding the rate of onset, intensity and duration of intoxication, and rate of recovery after volatile substance abuse. In addition, such knowledge is helpful when the clinician is attempting to interpret the results of toxicological analyses performed on samples (blood, other tissues, urine) from such patients. Many volatile substances are partly metabolised, the metabolites being eliminated in exhaled air or in urine. Although metabolism normally results in detoxification, enhanced toxicity may also result as with carbon tetrachloride, chloroform, dichloromethane, n-hexane, trichloroethylene and possibly halothane.
Identification of volatile substance abusers can be difficult, but the hair, breath and clothing may smell of solvent, and empty containers may be found. Perioral eczema (‘glue-sniffer’s rash’) from direct contact with glue poured into a plastic bag occurs rarely. Headspace gas chromatography of blood can detect exposure to many compounds but not to complex mixtures such as petrol; detection of metabolites is only useful with a few compounds, notably toluene, trichloroethylene and xylene.
Prevalence studies suggest that volatile substance abuse is increasing worldwide yet the UK is the only country to collate and regularly publish data on abuse-related deaths. Such data, although difficult to collect, are important in identifying and monitoring the problem. A coordinated approach to the collation of analogous data on an international basis would be valuable in monitoring the efficacy of preventative programmes.
Similar content being viewed by others
References
Allister C, Lush M, Oliver JS, Watson JM. Status epilepticus caused by solvent abuse. British Medical Journal 283: 1156, 1981
Altenkirch H, Kindermann W. Inhalant abuse and heroin addiction: a comparative study on 574 opiate addicts with and without a history of sniffing. Addictive Behaviours 11: 93–104, 1986
Altenkirch H, Mager J, Stoltenberg G, Helmbrecht J. Toxic polyneuropathies after sniffing a glue thinner. Journal of Neurology 214: 137–152, 1977
Andersen ME. Pharmacokinetics of inhaled gases and vapours. Neurobehavioural Toxicology and Teratology 3: 383–389,1981
Anderson HR, Macnair RS, Ramsey JD. Deaths from abuse of volatile substances: a national epidemiological study. British Medical Journal 290: 304–307, 1985
Arlien-Soborg P, Henriksen L, Gade A, Gyldensted C, Paulson OB. Cerebral blood flow in chronic toxic encephalopathy in house painters exposed to organic solvents. Acta Neurologica Scandinavica 66: 34–41, 1982
Arthur LJH, Curnock DA. Xylene-induced epilepsy following innocent glue sniffing. British Medical Journal 284: 1787, 1982
Astrand I. Uptake of solvents from the lungs. British Journal of Industrial Medicine 42: 217–218, 1985
Baader EW. Tatigkeitsbericht der Abteilung für gewerbekrankheiten des Kaiserin Auguste/Victoria/Krankenhauses in Berlin/Lichtenberg. Zentralblatt Gewerberhygeine 4: 385–399, 1927
Baerg RD, Kimberg DV. Centrilobular hepatic necrosis and acute renal failure in ‘solvent sniffers’. Annals of Internal Medicine 73: 713–720, 1970
Balasingam S, Chan A. Cardiac beri beri — an old disease in modern Singapore — 2 case reports. Annals of the Academy of Medicine 12: 614–619, 1983
Balster RL. Abuse potential evaluation of inhalants. Drug and Alcohol Dependence 19: 7–15, 1987
Bartolucci G, Pellettier JR. Glue sniffing and movement disorder. Journal of Neurology, Neurosurgery and Psychiatry 47: 1259, 1984
Baselt RC. Disposition of toxic drugs and chemicals in man, 2nd ed., Biomedical Publications, Davis, California, 1982
Bass M. Sudden sniffing death. Journal of the American Medical Association 212: 2075–2079, 1970
Bennett RH, Forman HR. Hypokalemic periodic paralysis in chronic toluene exposure. Archives of Neurology 37: 673, 1980
Bonzel K-E, Muller-Wiefel DE, Ruder H, Wingen A-M, Waldherr R, et al. Anti-glomerular basement membrane antibody-mediated glomerulonephritis due to glue sniffing. European Journal of Paediatrics 146: 296–300, 1987
Boor JW, Hurtig HI. Persistent cerebellar ataxia after exposure to toluene. Annals of Neurology 2: 440–442, 1977
Brecher E. Licit and illicit drugs, Little Brown, Boston, 1974
Brennan PO. Addiction to aerosol treatment. British Medical Journal 287: 1877, 1983
Brown WD, Setzer JV, Dick RB, Phipps FC, Lowry LK. Body burden profiles of single and mixed solvent exposures. Journal of Occupational Medicine 29: 877–883, 1987
Caligiuri MA, Early AP, Marinello MJ, Preisler HD. Acute non-lymphocytic leukemia in a glue sniffer. American Journal of Hematology 20: 89–90, 1985
Cameron JS. Solvent abuse: a guide for the carer, Croom Helm, London, 1988
Campbell L, Marsh M, Wilson HK. Towards a biological monitoring strategy for toluene. Annals of Occupational Hygiene 31: 121–133, 1987
Carlini-Cotrim B, Carlini EA. The use of solvents and other drugs among children and adolescents from a low socioeconomic background: a study in Sao Paulo, Brazil. International Journal of the Addictions 23: 1145–1156, 1988
Carlton RF. Fluorocarbon toxicity: deaths and anaesthetic reactions. Annals of Clinical and Laboratory Science 6: 411–414, 1976
Chadwick O, Anderson HR. Neuropsychological consequences of volatile substance abuse: a review. Human Toxicology 8: 307–312, 1989
Chadwick O, Anderson HR, Bland M, Ramsey J. Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. British Medical Journal 298: 1679–1684, 1989
Chessare JB, Wodarcyk K. Gasoline sniffing and lead poisoning in a child. American Family Physician 38: 181–182, 1988
Chowdhury JK. Acute ventilatory failure from sniffing paint. Chest 71: 687–688, 1977
Christensen H, Lenler-Petersen P, Kristoffersen E. Ventricular fibrillation after sniffing lighter fuel. Ugeskrift for Laeger 150: 869–870, 1988
Clark DG, Tinston DJ. Acute inhalation toxicity of some halogenated and non-halogenated hydrocarbons. Human Toxicology 1: 239–247, 1982
Claydon SM. Myocardial degeneration in chronic solvent abuse. Medicine, Science and the Law 28: 217–218, 1988
Clearfield HR. Hepatorenal toxicity from sniffing spot-remover (trichloroethylene). Digestive Diseases 15: 851–856, 1970
Clinger DW, Johnson MA. Purposeful inhalation of gasoline vapours. Psychiatric Quarterly 25: 555–561, 1951
Cohen S. The intentional inhalation of volatile substances. Advances in Substance Abuse 2: 123–143, 1981
Cole M, Herndon HN, Desai MH, Abston S. Gasoline explosions, gasoline sniffing: an epidemic in young adolescents. Journal of Burn Care and Rehabilitation 7: 532–534, 1986
Cooke BR, Evans DA, Farrow SC. Solvent misuse in secondary school children: a prevalence study. Community Medicine 10: 8–13, 1988
Cooper R, Newton P, Reed M. Neurophysiological signs of brain damage due to glue sniffing. Electroencephalography and Clinical Neurophysiology 60: 23–26, 1985
Costero I, Barroso R. Alteraciones encontradas en gatos intoxicados experimentale con inhalaciones de disolventes industriales. In Contreras (Ed.) Inhalación voluntaria de disolventes industrials, pp. 163–185, Trillas, Mexico, 1977
Coulehan JL, Hirsch W, Brillman J, Sanandria J, Welty TK, et al. Gasoline sniffing and lead toxicity in Navajo adolescents. Pediatrics 71: 113–117, 1983
Cronk SL, Barkley DEH, Farrell MF. Respiratory arrest after solvent abuse. British Medical Journal 290: 897–898, 1985
Cunningham SR, Dalzell GWN, McGirr P, Khan MM. Myocardial infarction and primary ventricular fibrillation after glue sniffing. British Medical Journal 294: 739–740, 1987
D’Amanda C, Plumb MM, Taintor Z. Heroin addicts with a history of glue sniffing: a deviant group within a deviant group. International Journal of the Addictions 12: 255–270, 1977
Daniel DR, McAnalley BH, Garriott JC. Isopropyl alcohol metabolism after acute intoxication in humans. Journal of Analytical Toxicology 5: 110–112, 1981
Daniels AM, Latcham RW. Petrol sniffing and schizophrenia in a Pacific island paradise. Lancet 1: 389, 1984
Davidman M, Schmitz P. Renal tubular acidosis: a pathophysiologic approach. Hospital Practice 23: 77–96, 1988
Devathasan G, Low D, Teoh PC, Wan SH, Wong PK. Complications of chronic glue (toluene) abuse in adolescents. Australian and New Zealand Medical Journal 14: 39–43, 1984
Diamond ID, Pritchard C, Choudry N, Fielding M, Cox M, et al. The incidence of drug and solvent misuse among southern English normal comprehensive schoolchildren. Public Health 102: 107–114, 1988
Ducatman AM, Moyer TP. Environmental exposure to common industrial solvents. American Association for Clinical Chemistry: TDM-Toxicology 5: 1–18, 1984
Edeh J. Volatile substance abuse in relation to alcohol and illicit drugs: psychosocial perspectives. Human Toxicology 8: 313–317, 1989
Edh M, Selerud A, Sjoberg C. Death and sniffing: a report on 63 cases. Svenska Lakartidningen 70: 3949–3959, 1973
Ehyai A, Freemon FR. Progressive optic neuropathy and senso-rineural hearing loss due to chronic glue sniffing. Journal of Neurology, Neurosurgery and Psychiatry 46: 349–351, 1983
Escobar A, Arutto C. Chronic thinner intoxication: clinicopathologic report of a human case. Journal of Neurology, Neurosurgery and Psychiatry 43: 986–994, 1980
Evans AC, Raistrick D. Patterns of use and related harm with toluene-based adhesives and butane gas. British Journal of Psychiatry 150: 773–776, 1987a
Evans AC, Raistrick D. Phenomenology of intoxication with toluene-based adhesives and butane gas. British Journal of Psychiatry 150: 769–773, 1987b
Fischman CM, Oster JR. Toxic effects of toluene: a new cause of high anion gap metabolic acidosis. Journal of the American Medical Association 241: 1713–1715, 1979
Fiserova-Bergerova V. Modelling of inhalation exposure to vapours: uptake, distribution and elimination, vols I & II, CRC Press, Boca Raton, 1983
Fishbeck WA, Langner RR, Kociba DV. Elevated urinary phenol not related to benzene exposure. American Industrial Hygiene Association Journal 36: 820–824, 1975
Flanagan RJ. The role of acetylcysteine in clinical toxicology. Medical Toxicology 2: 93–104, 1987
Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurologica Scandinavica 67: 319–329, 1983
Funes-Cravioto F, Zapata-Gayon C, Kolmodin-Hedman B, Lambert B, Lindsten J, et al. Chromosome aberrations and sister-chromatid exchange in workers in chemical laboratories and a rotoprinting factor and in children of women laboratory workers. Lancet 2: 322–325, 1977
Garriott JC, Foerster E, Juarez L, de la Garza F, Mendiola I, et al. Measurement of toluene in blood and breath in cases of solvent abuse. Clinical Toxicology 18: 471–479, 1981
Garriott J, Petty CS. Death from inhalant abuse: toxicological and pathological evaluation of 34 cases. Clinical Toxicology 16: 305–315, 1980
Gill R, Hatchett SE, Osselton MD, Wilson HK, Ramsey JD. Sample handling and storage for the quantitative analysis of volatile compounds in blood: the determination of toluene by headspace gas chromatography. Journal of Analytical Toxicology 12: 141–146, 1988
Gompertz D. Solvents — the relationship between biological monitoring strategies and metabolic handling: a review. Annals of Occupational Hygiene 23: 405–410, 1980
Grabski DA. Toluene sniffing producing cerebellar degeneration. American Journal of Psychiatry 118: 461–462, 1961
Gunn J, Wilson J, Mackintosh AF. Butane sniffing causing ventricular fibrillation. Lancet 1: 617, 1989
Halevy J, Pitlik S, Rosenfeld J, Eitan B-D. 1,1,1-Trichloroethane intoxication; a case report with transient liver and renal damage: review of the literature. Clinical Toxicology 16: 467–472, 1980
Hamilton DV, Thiru S, Evans DB. Renal damage and glue sniffing. British Medical Journal 284: 117, 1982
Hansen AC, Knudsen PJT. Fatal lighter-gas sniffing. Ugeskrift for Laeger 150: 867–869, 1988
Haverkos HW, Dougherty JA (Eds). Health hazards of nitrite inhalants, NI DA Research Monograph 83, US Government Printing Office, Washington, 1988
Hayden JW, Comstock EG, Comstock BS. The clinical toxicology of solvent abuse. Clinical Toxicology 9: 169–184, 1976
Hecht F, Hecht BK. Editorial: environmental chromosome damage. American Journal of Medical Genetics 27: 399–400, 1987
Helliwell M, Murphy M. Drug-induced neurological disease. British Medical Journal 1: 1283–1284, 1979
Hershey CO, Miller S. Solvent abuse: a shift to adults. International Journal of the Addictions 17: 1085–1089, 1982
Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapour abuse. Neurology 36: 698–702, 1986
Ikeda M, Imamura T, Hayashi M, Tabachi T, Hara I. Evaluation of hippuric, phenylglyoxylic and mandelic acids in urine as indices of styrene exposure. International Archiv für Arbeitsmedizin 32: 93–101, 1974
Iregren A. Effects on human performance from acute and chronic exposure to organic solvents: a short review. Toxicology 49: 349–358, 1988
Isager H. Fatal aplasia of bone marrow after inhalation of vapour from toluene containing glue. Ugeskrift for Laeger 137: 2197–2198, 1975
Jacobs AM, Ghodse AH. Delinquency and regular solvent abuse: an unfavourable combination? British Journal of Addiction 83: 965–968, 1988
Johnson BP, Meredith TJ, Vale JA. Cerebellar dysfunction after acute tetrachloride poisoning. Lancet 2: 968, 1983
Jone CM, Wu AHB. An unusual case of toluene-induced metabolic acidosis. Clinical Chemistry 34: 2596–2599, 1988
Kelly TW. Prolonged cerebellar dysfunction associated with paint-sniffing. Pediatrics 56: 605–606, 1975
King MD, Day RE, Oliver JS, Lush M, Watson JM. Solvent encephalopathy. British Medical Journal 283: 663–665, 1981
Kira S, Ogata M, Ebara Y, Horii S, Otsuki S. A case of thinner sniffing: relationship between neuropsychological symptoms and urinary findings after inhalation of toluene and methanol. Industrial Health 26: 81–85, 1988
Kopelman PG, Kalfayan PY. Severe metabolic acidosis after ingestion of butanone. British Medical Journal 286: 21–22, 1983
Koppel C, Lanz H-J, Ibo K. Acute trichloroethylene poisoning with additional ingestion of ethanol — concentrations of trichloroethylene and its metabolites during hyperventilation therapy. Intensive Care Medicine 14: 74–76, 1988
Kringsholm B. Sniffing associated deaths in Denmark. Forensic Science International 15: 215–225, 1980
Kroeger RM, Moore RJ, Lehman TH, Giesy JD, Skeeters CE. Recurrent urinary calculi associated with toluene sniffing. Journal of Urology 123: 89–91, 1980
Lamont CM, Adams FG. Glue-sniffing as a cause of a positive radio-isotope brain scan. European Journal of Nuclear Medicine 7: 387–388, 1982
Lavik NJ. Drug abuse among junior high school students in Norway. Pediatrician 14: 46–50, 1987
Layzer RB. Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 2: 1227–1230, 1978
Lee JT. Volatile substance abuse within a health education context. Human Toxicology 8: 331–334, 1989
Leonard JV, Middleton B, Seakins JWT. Acetoacetyl CoA thiolase deficiency presenting as ketotic hypoglycaemia. Pediatric Research 21: 211–213, 1987
Liss BI. Government, trade and industry and other preventative responses to volatile substance abuse. Human Toxicology 8: 327–330, 1989
Litovitz T, Greene AE. Health implications of petroleum distillate ingestion. State of the Art Reviews in Occupational Medicine 3: 555–568, 1988
Litt IF, Cohen MI. ‘Danger’. vapour harmful’: spot remover sniffing. New England Journal of Medicine 281: 543–544, 1969
Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Human Toxicology 8: 293–300, 1989
Low LK, Meeks JR, Mackerer CR. Health effects of the alkyl-benzenes I: toluene. Toxicology and Industrial Health 4: 49–75, 1988
Mackay CJ, Campbell L, Samuel AM, Alderman KJ, Idzikowski C, et al. Behavioural changes during exposure to 1,1,1-trichloroethane: time-course and relationship to blood solvent levels. American Journal of Industrial Medicine 11: 223–239, 1987
Mapleson WW. Pharmacokinetics of inhaled anaesthetics. In Prys-Roberts & Hug (Eds) Pharmacokinetics of anaesthesia, pp. 89–111, Blackwell, Oxford, 1984
Marjot R, McLeod AA. Chronic non-neurological toxicity from volatile substance abuse. Human Toxicology 8: 301–306, 1989
Matoba R, Funahashi M, Fujitani N, Abe T, Nogi H, et al. An autopsy case of sudden death after toluene sniffing. Nippon Hoigaku Zasshi 41: 438–441, 1987
McCarthy TB, Jones RD. Industrial gassing poisonings due to trichloroethylene, perchloroethylene, and 1-1-1 trichloroethane, 1961–80. British Journal of Industrial Medicine 40: 450–455, 1983
McCracken JT. Lead intoxication psychosis in an adolescent. Journal of the American Academy of Child and Adolescent Psychiatry 26: 274–276, 1987
McGee MB, Jejurikar SG, VanBerkom LC. A double homicide as a result of chloroform poisoning. Journal of Forensic Sciences 32: 1453–1459, 1987
McHugh MJ. The abuse of volatile substances. Pediatric Clinics of North America 34: 333–340, 1987
McLeod AA, Marjot R, Monaghan MJ, Hugh-Jones P, Jackson G. Chronic cardiac toxicity after inhalation of 1,1,1-trichloroethane. British Medical Journal 294: 727–729, 1987
Meckler LC, Phelps DK. Liver disease secondary to tetrachloroethylene exposure: a case report. Journal of the American Medical Association 197: 662–663, 1966
Mee AS, Wright PL. Congested (dilated) cardiomyopathy in association with solvent abuse. Journal of the Royal Society of Medicine 73: 671–672, 1980
Melamed E, Lavy S. Parkinsonism associated with chronic inhalation of carbon tetrachloride. Lancet 1: 1015, 1977
Meredith TJ, Ruprah M, Liddle A, Flanagan RJ. Diagnosis and treatment of acute poisoning with volatile substances. Human Toxicology 8: 277–286, 1989
Moffat AC (Ed.). Clarke’s isolation and identification of drugs. 2nd ed., Pharmaceutical Press, London, 1986
Moss AH, Gabow PA, Kaehny WD, Goodman SI, Haut LL. Fanconi’s syndrome and distal renal tubular acidosis after glue sniffing. Annals of Internal Medicine 92: 69–70, 1980
Nathan AW, Toseland PA. Goodpasture’s syndrome and 1,1,1-trichloroethane intoxication. British Journal of Clinical Pharmacology 8: 284–286, 1979
Neuberger JM. Halothane and hepatitis: incidence, predisposing factors and exposure guidelines. Drug Safety 5: 28–38, 1990
Nevins MA. Two cases of neuropathy after nitrous oxide abuse. Journal of the American Medical Association 244: 2264, 1980
Nordin C, Rosenqvist M, Hollstedt C. Sniffing of ethyl chloride — an uncommon form of abuse with serious mental and neurological symptoms. International Journal of the Addictions 23: 623–627, 1988
O’Brien ET, Yeoman WB, Hobby JAE. Hepatorenal damage from toluene in a ‘glue sniffer’. British Medical Journal 2: 29–30, 1971
O’Callaghan C, Milner AD. Aerosol treatment abuse. Archives of Disease in Childhood 63: 70, 1988
Ogawa Y, Takatsuki R, Uema T, Seki Y, Hiramatsu K, et al. Acute optic neuropathy induced by thinner sniffing: inhalation of mixed organic solvent containing methyl alcohol and methyl acetate. Industrial Health 26: 239–244, 1988
Okwumabua JO, Duryea EJ. Age of onset, periods of risk, and patterns of progression in drug use among American Indian high school students. International Journal of the Addictions 22: 1269–1276, 1987
Oliver JS. Solvent abuse. In Curry (Ed.) Analytical methods in human toxicology, pp. 89–100, Macmillan, London, 1984
Patel R, Benjamin J. Renal disease associated with toluene inhalation. Clinical Toxicology 24: 213–223, 1986
Parker MJ, Tarlow MJ, Anderson JM. Glue-sniffing and cerebral infarction. Archives of Disease in Childhood 59: 675–677, 1984
Pozzi C, Marai P, Ponti R, Dell’Oro C, Sala C, et al. Toxicity in man due to stain removers containing 1,2-dichloropropane. British Journal of Industrial Medicine 42: 770–772, 1985
Pratt HF. Abuse of salbutamol inhalers in young people. Clinical Allergy 12: 203–209, 1982
Rafferty P. Voluntary chlorine inhalation: a new form of self-abuse? British Medical Journal 281: 1178–1179, 1980
Ramsey JD. Detection of solvent abuse by direct mass spectrometry on expired air. In Reid & Wilson (Eds) Drug determination in therapeutic and forensic contexts, pp. 357–362, Plenum, New York, 1984
Ramsey JD, Anderson HR, Bloor K, Flanagan RJ. An introduction to the practice, prevalence and chemical toxicology of volatile substance abuse. Human Toxicology 8: 261–269, 1989
Ramsey JD, Flanagan RJ. Detection and identification of volatile organic compounds in blood by headspace gas chromatography as an aid to the diagnosis of solvent abuse. Journal of Chromatography 240: 423–444, 1982
Reyes de la Rocha S, Brown MA, Fortenberry JD. Pulmonary function abnormalities in intentional spray paint inhalation. Chest 92: 100–104, 1987
Riihimaki V, Ulfvarson U (Eds) Safety and health aspects of organic solvents, Alan R Liss, New York, 1986
Rischbieth RH, Thompson GN, Hamilton-Bruce A, Purdie GH, Peters JH. Acute encephalopathy following petrol sniffing in two aboriginal patients. Clinical and Experimental Neurology 23: 191–194, 1987
Robert R, Touchard G, Meurice J-C, Pourrat O, Yver L. Severe Goodpasture’s syndrome after glue sniffing. Nephrology, Dialysis, Transplantation 3: 483–484, 1988
Ron MA. Volatile substance abuse: a review of possible long-term neurological, intellectual and psychiatric sequelae. British Journal of Psychiatry 148: 235–246, 1986
Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, Dreisbach JN, Hormes JT, et al. Toluene abuse causes diffuse central nervous system white matter changes. Annals of Neurology 23: 611–614, 1988
Ruprah M, Mant TGK, Flanagan RJ. Acute carbon tetrachloride poisoning in 19 patients: implications for diagnosis and treatment. Lancet 1: 1027–1029, 1985
Russ G, Clarkson AR, Woodroffe AJ, Seymour AE, Cheng IKP. Renal failure from ‘glue sniffing’. Medical Journal of Australia 2: 121–122, 1981
Salamanca-Gómez F, Moreta G, Palma V, Garcia T, Navarrete C, et al. Cytogenetic study in children chronically habituated to inhalation of volatile substances. American Journal of Medical Genetics 27: 391–397, 1987
Salamanca-Gómez F, Palma V, Navarrete C, Garcia T, Moreta G, et al. Chromosome abnormalities and sister chromatid exchanges in children with acute intoxication due to inhalation of volatile substances. Archives of Environmental Health 44: 49–53, 1989
Sasa M, Igarashi S, Miyazaki T, Miyazaki K, Nakano S, et al. Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing. Archives of Oto-Rhino-Laryngology 221: 163–169, 1978
Seage AJ, Burns MW. Pulmonary oedema following exposure to trichloroethylene. Medical Journal of Australia 2: 484–486, 1971
Schikler KN, Une EE, Seitz K, Collins WM. Solvent abuse associated pulmonary abnormalities. Advances in Alcohol and Substance Abuse 3: 75–81, 1984
Schikler KN, Seitz K, Rice JF, Strader T. Solvent abuse associated cortical atrophy. Journal of Adolescent Health Care 3: 37–39, 1982
Sharp CW, Korman M. Volatile substances. In Lowinson Ruiz (Eds) Substance abuse: clinical problems and perspectives, pp. 39–42, Williams and Wilkins, Baltimore, 1981
Shepherd RT. Mechanism of sudden death associated with volatile substance abuse. Human Toxicology 8: 287–291, 1989
Sourindhrin I, Baird JA. Management of solvent abuse: a Glasgow community approach. British Journal of Addiction 79: 227–232, 1984
Storms WW. Chloroform parties. Journal of the American Medical Association 225: 160, 1973
Streicher HZ, Gabow PA, Moss AH, Kono D, Kaehny WD. Syndromes of toluene sniffing in adults. Annals of Internal Medicine 94: 758–762, 1981
Suzuki T, Kashimura S, Umetsu K. Thinner abuse and aspermia. Medicine, Science and the Law 23: 199–202, 1983
Suzuki T, Shimbo S, Nishitani H, Oga T, Imamura T, et al. Muscular atrophy due to glue sniffing. International Archiv für Arbeitsmedizin 33: 115–123, 1974
Swadi H. Drug and substance use among 3,333 London adolescents. British Journal of Addiction 83: 935–942, 1988
Taher SM, Anderson RJ, McCartney R, Popovtzer MM, Schrier RW. Renal tubular acidosis associated with toluene ‘sniffing’. New England Journal of Medicine 290: 765–768, 1974
Taverner D, Harrison DJ, Bell GM. Acute renal failure due to interstitial nephritis induced by ‘glue-sniffing’ with subsequent recovery. Scottish Medical Journal 33: 246–247, 1988
Teck-Hong O. Inhalant abuse in Singapore. International Journal of the Addictions 21: 955–960, 1986
Thompson PJ, Dhillon P, Cole P. Addiction to aerosol treatment: the asthmatic alternative to glue sniffing. British Medical Journal 287: 1515, 1983
Toftgård R, Gustafsson J-Å. Biotransformation of organic solvents: a review. Scandinavian Journal of Work and Environmental Health 6: 1–18, 1980
Toutant C, Lippmann S. Fetal solvents syndrome. Lancet 1: 1356, 1979
Vaille C. Des toxicomanies aux inhalants. Hygie 7: 13–17, 1988
van Doom R, Delbressine LPC, Leijdekkers CM, Vertin PG, Henderson PTH. Identification and determination of 2-thiothiazolidine-4-carboxylic acid in urine of workers exposed to carbon disulphide. Archives of Toxicology 47: 51–58, 1981
Venkataraman G. Renal damage and glue sniffing. British Medical Journal 283: 1467, 1981
Veulemans H, Masschelein R. Experimental human exposure to toluene III: urinary hippuric acid excretion as a measure of individual solvent uptake. International Archives of Occupational and Environmental Health 43: 53–62, 1979
Voigts A, Kaufman CE. Acidosis and other metabolic abnormalities associated with paint sniffing. Southern Medical Journal 76: 443–452, 1983
Wallace LA. The exposure of the general population to benzene. Cell Biology and Toxicology 5: 297–314, 1989
Wallén M, Naslund PH, Byfalt Nordqvist M. The effects of ethanol on the kinetics of toluene in man. Toxicology and Applied Pharmacology 76: 414–419, 1984
Wasan S, Gibier WB, Hassan M. Ventricular tachycardia associated with non-freon aerosol propellants. Journal of the American Medical Association 256: 78–80, 1986
Watson DS. Petrol abuse at Elcho Island: an attempted intervention. Australian Paediatric Journal 22: 277–279, 1986
Watson JM. Solvent abuse: prevention and clinical diagnosis. Human Toxicology 1: 249–256, 1981
Watson JM. Solvent abuse: the adolescent epidemic? Croom Helm, London, 1986
Westermeyer J. The psychiatrist and solvent-inhalant abuse: recognition, assessment and treatment. American Journal of Psychiatry 144: 903–907, 1987
Will AM, McLaren EH. Reversible renal damage due to glue sniffing. British Medical Journal 283: 525–526, 1981
Williams DM. Hearing loss in a glue sniffer. Journal of Otolar-yngology 17: 321–324, 1988
Wilson HK, Robertson SM, Waldron HA, Gompertz D. Effect of alcohol on the kinetics of mandelic acid excretion in volunteers exposed to styrene vapour. British Journal of Industrial Medicine 40: 75–80, 1983
Wiseman MN, Banim S. ‘Glue sniffer’s’ heart? British Medical Journal 294: 739, 1987
Wodka RM, Jeong EWS. Cardiac effects of inhaled typewriter correction fluid. Annals of Internal Medicine 110: 91–92, 1989
Zee-Cheng C-S, Mueller CE, Gibbs HR. Toluene sniffing and severe sinus bradycardia. Annals of Internal Medicine 103: 482, 1985
Author information
Authors and Affiliations
Additional information
The contents of this article represent the authors’ views alone and in no way commit the Department of Health.
Rights and permissions
About this article
Cite this article
Flanagan, R.J., Ruprah, M., Meredith, T.J. et al. An Introduction to the Clinical Toxicology of Volatile Substances. Drug-Safety 5, 359–383 (1990). https://doi.org/10.2165/00002018-199005050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199005050-00005